IGFBP2 and metastatic malignant neoplasm in the lymph nodes: In metastatic breast cancer, tumor-secreted IGFBP2 recruits endothelial cells—a hallmark of metastatic dissemination (68)—while synergizing with β-catenin to promote lymph node metastasis (69, 70).